1510829-06-7 (Vecabrutinib,Vecabrutinib)

Vecabrutinib;PQ7O0OB5GU;SNS062;FP0182;(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxo[1,3'-bipiperidine]-4'-carboxamide;Vecabrutinib [INN];Vecabrutinib [USAN];Vecabrutinib (USAN/INN);Vecabrutinib [USAN:INN];BIIB062;GTPL10231;(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide;BCP29646;SNS-062;AC-36339;FP-182;BSK-4841;(3R,3'R,4'S)-1'-(6-AMINO-5-FLUOROPYRIMIDIN-4-YL)-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)AMINO)-2-OXO-(1,3'-BIPIPERIDINE)-4'-CARBOXAMIDE;WHO 10643;BDBM50546200;NSC-810114;UNII-PQ7O0OB5GU;DA-78850;EX-A3159;(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-{[3-chloro-5-(trifluoromethyl)phenyl]amino}-2-oxo-[1,3'-bipiperidine]-4'-carboxamide;BIIB-062;HY-109078;AKOS040742809;(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-((3-chloro-5-(trifluoromethyl)phenyl)amino)-2-oxo-[1,3'-bipiperidine]-4'-carboxamide;ZB1596;QLRRJMOBVVGXEJ-XHSDSOJGSA-N;(1,3'-BIPIPERIDINE)-4'-CARBOXAMIDE, 1'-(6-AMINO-5-FLUORO-4-PYRIMIDINYL)-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)AMINO)-2-OXO-, (3R,3'R,4'S)-;VECABRUTINIB [WHO-DD];D11428;CS-0033553;CHEMBL4297640;G16371;NSC810114;SCHEMBL16765727;MS-29801;FP-0182;1510829-06-7;

QLRRJMOBVVGXEJ-XHSDSOJGSA-N

1S/C22H24ClF4N7O2/c23-12-6-11(22(25,26)27)7-13(8-12)32-15-2-1-4-34(21(15)36)16-9-33(5-3-14(16)19(29)35)20-17(24)18(28)30-10-31-20/h6-8,10,14-16,32H,1-5,9H2,(H2,29,35)(H2,28,30,31)/t14-,15+,16-/m0/s1

ClC1C=C(C(F)(F)F)C=C(C=1)N[C@@H]1CCCN(C1=O)[C@H]1CN(C2C(=C(N)N=CN=2)F)CC[C@@H]1C(N)=O